Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Disease

Metabolic Dysfunction Associated Steatohepatitis (MASH)

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · PHASE 2 TRIAL

A Study of CS060380 Tablets in Patients With MASH and Obesity

ClinicalTrials.gov

Phase 2 interventional trial in recruitment with no posted results; represents early-stage efficacy and safety testing of an investigational drug combination.

PreliminaryNCT07466017 Obesity CS060380

Reported

Planned enrollment130

PhasePhase 2

Primary outcome measurePercentage change in liver fat content from…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support